Arcturus Therapeutics Holdings Inc.
ARCT
$14.74
-$0.89-5.69%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -93.28M | -78.67M | -65.78M | -66.71M | -60.16M |
| Total Depreciation and Amortization | 2.75M | 2.88M | 3.03M | 3.16M | 3.31M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 23.26M | 25.30M | 27.69M | 27.72M | 31.52M |
| Change in Net Operating Assets | -5.46M | -8.08M | -39.20M | -22.50M | -39.61M |
| Cash from Operations | -72.73M | -58.57M | -74.27M | -58.33M | -64.94M |
| Capital Expenditure | -93.00K | -93.00K | -230.00K | -318.00K | -217.00K |
| Sale of Property, Plant, and Equipment | 52.00K | 34.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -41.00K | -59.00K | -230.00K | -318.00K | -217.00K |
| Total Debt Issued | 0.00 | 0.00 | 15.00M | 15.00M | 15.00M |
| Total Debt Repaid | 0.00 | -15.00M | -15.00M | -15.00M | -15.00M |
| Issuance of Common Stock | 12.93M | 13.20M | 13.38M | 1.83M | 1.30M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 12.93M | -1.80M | 13.38M | 1.83M | 1.30M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -59.84M | -60.43M | -61.12M | -56.82M | -63.86M |